Dexlansoprazole-Acino 30 mg
Dexlansoprazole-Acino 30 mg is a medicine authorised by Swissmedic under authorisation number 67981. The authorisation holder is Acino Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 September 2020 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 67981 |
|---|---|
| Name | Dexlansoprazole-Acino 30 mg |
| Full name | Dexlansoprazole-Acino 30 mg, Kapseln mit veränderter Wirkstofffreisetzung |
| Authorisation holder | Acino Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 16 September 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dexlansoprazole-Acino 30 mg, Kapseln mit veränderter Wirkstofffreisetzung | B | 16 September 2020 |
| 2 | Dexlansoprazole-Acino 60 mg, Kapseln mit veränderter Wirkstofffreisetzung | B | 16 September 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Dexlansoprazole-Acino 30 mg authorised in Switzerland?
Yes. Dexlansoprazole-Acino 30 mg is authorised by Swissmedic under authorisation number 67981, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dexlansoprazole-Acino 30 mg have?
Dexlansoprazole-Acino 30 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dexlansoprazole-Acino 30 mg?
The authorisation holder is Acino Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.